232. Alpha-1 Antitrypsin (AAT) Expression 1 Year after IM Administration of rAAV1-CB-hAAT in a Phase 2 Clinical Trial

Molecular Therapy ◽

10.1016/s1525-0016(16)36036-1 ◽

2012 ◽

Vol 20 ◽

pp. S231-S232

Keyword(s):

Clinical Trial ◽

Phase 2 ◽

Phase 2 Clinical Trial ◽

Alpha 1 Antitrypsin

Download Full-text

49. Transgene T Cell Response in a Phase 2 Clinical Trial of rAAV1.Alpha-1 Antitrypsin Gene Therapy Vector: CD8+ Mediated and HLA C*05 Restricted

Molecular Therapy ◽

10.1016/s1525-0016(16)35853-1 ◽

2012 ◽

Vol 20 ◽

pp. S20

Keyword(s):

Clinical Trial ◽

Gene Therapy ◽

T Cell ◽

Cell Response ◽

T Cell Response ◽

Phase 2 ◽

Gene Therapy Vector ◽

Phase 2 Clinical Trial ◽

Alpha 1 Antitrypsin

Download Full-text

Phase 2 Clinical Trial Of A Recombinant Adeno-Associated Virus (RAAV) Alpha-1 Antitrypsin (AAT) Gene Therapy Vector

10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a2428 ◽

2011 ◽

Author(s):

Terence Flotte ◽

Bruce Trapnell ◽

Margaret Humphries ◽

Brenna Carey ◽

Roberto Calcedo ◽

...

Keyword(s):

Clinical Trial ◽

Gene Therapy ◽

Phase 2 ◽

Adeno Associated Virus ◽

Gene Therapy Vector ◽

Phase 2 Clinical Trial ◽

Alpha 1 Antitrypsin

Download Full-text

Comparison of a Novel Tazarotene 0.045% Lotion to Tazarotene 0.1% Cream: Patient-Reported Outcomes from a Phase 2 Clinical Trial

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.3.supp.9 ◽

2019 ◽

Vol 3 ◽

pp. S9

Author(s):

Zoe Draelos ◽

Fran Cook-Bolden ◽

Lawrence Green ◽

Eric Guenin ◽

Gina Martin ◽

...

Keyword(s):

Clinical Trial ◽

Patient Reported Outcomes ◽

Phase 2 ◽

Patient Reported ◽

Phase 2 Clinical Trial

Abstract not available.

Download Full-text

Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas

Case Medical Research ◽

10.31525/ct1-nct04283669 ◽

2020 ◽

Author(s):

Keyword(s):

Clinical Trial ◽

Neurofibromatosis Type ◽

Neurofibromatosis Type 2 ◽

Vestibular Schwannomas ◽

Phase 2 ◽

Phase 2 Clinical Trial

Download Full-text

Faculty Opinions recommendation of Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in Thailand.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1047842.497861 ◽

2006 ◽

Author(s):

David Sullivan

Keyword(s):

Clinical Trial ◽

Plasmodium Falciparum ◽

Combination Therapy ◽

Falciparum Malaria ◽

Plasmodium Falciparum Malaria ◽

Phase 2 ◽

Phase 2 Clinical Trial ◽

Uncomplicated Plasmodium Falciparum Malaria ◽

Randomized Phase 2

Download Full-text

Faculty Opinions recommendation of Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas: A Phase 2 Clinical Trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727784209.793552909 ◽

2018 ◽

Author(s):

Warren A Chow

Keyword(s):

Clinical Trial ◽

Macrophage Infiltration ◽

Phase 2 ◽

Pathway Activation ◽

Phase 2 Clinical Trial

Download Full-text

Phase 2 Clinical Trial of Intraoral Grafting of Human Tissue-Engineered Oral Mucosa

10.21236/ada591622 ◽

2013 ◽

Author(s):

Stephen E. Feinberg

Keyword(s):

Clinical Trial ◽

Oral Mucosa ◽

Human Tissue ◽

Phase 2 ◽

Phase 2 Clinical Trial

Download Full-text

A Descriptive Cost‐Analysis of MYX.1/MCRN003, a Phase 2 Clinical Trial Evaluating High‐dose Weekly Carfilzomib, Cyclophosphamide, and Dexamethasone in Relapsed and Refractory Multiple Myeloma

European Journal Of Haematology ◽

10.1111/ejh.13671 ◽

2021 ◽

Author(s):

Bethany E. Monteith ◽

Christopher P. Venner ◽

Matthew C. Cheung ◽

Joe Pater ◽

Lois Shepherd ◽

...

Keyword(s):

Clinical Trial ◽

Multiple Myeloma ◽

Cost Analysis ◽

High Dose ◽

Phase 2 ◽

Refractory Multiple Myeloma ◽

Phase 2 Clinical Trial

Download Full-text

Number Needed to Treat and Number Needed to Harm analysis of the zuranolone phase 2 clinical trial results in major depressive disorder

Journal of Affective Disorders ◽

10.1016/j.jad.2021.02.027 ◽

2021 ◽

Vol 285 ◽

pp. 112-119

Author(s):

Alix Arnaud ◽

Ellison Suthoff ◽

Katie Stenson ◽

Brian Werneburg ◽

Paul Hodgkins ◽

...

Keyword(s):

Clinical Trial ◽

Major Depressive Disorder ◽

Depressive Disorder ◽

Number Needed To Treat ◽

Phase 2 ◽

Major Depressive ◽

Phase 2 Clinical Trial ◽

Clinical Trial Results ◽

Number Needed To Harm

Download Full-text

41. Repeated Autologous Infusions of Cells Modified with VSV-G-Pseudotyped Lentiviral Vector VRX496 Can Induce Anti-VSV-G Humoral Response in Humans without Clinical Consequence or Effect on Modified Cells Persistence: Findings from Lexgenleucel-T Phase 2 Clinical Trial

Molecular Therapy ◽

10.1016/s1525-0016(16)37482-2 ◽

2010 ◽

Vol 18 ◽

pp. S17-S18

Keyword(s):

Clinical Trial ◽

Lentiviral Vector ◽

Humoral Response ◽

Clinical Consequence ◽

Phase 2 ◽

Phase 2 Clinical Trial ◽

Download Full-text